Unipezil Tablet 23 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.
MFDS item code 202102917 · Approved 2021.04.05
Treatment of symptoms of moderate to severe Alzheimer’s-type dementia
This medication is used to treat moderate to severe symptoms of Alzheimer-type dementia. It helps alleviate cognitive impairment and behavioral problems caused by dementia, thereby improving the patient's ability to perform daily activities. It contributes to the enhancement of quality of life through symptom relief.
Take this medicine once daily in the evening, immediately before bedtime, with or without food. If sleep disturbances such as unusual dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Do not split, crush, or chew this medicine, as doing so may increase the rate of absorption. The recommended initial dose of donepezil hydrochloride is 5mg once daily. This medicine reaches steady state 15 days after administration, and the incidence of adverse reactions may be affected by the rate of dose escalation; therefore, administer 5mg for 4 ~ 6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10mg. When increasing the dose to 10mg daily, administer with caution for gastrointestinal adverse reactions. A dose of 23mg once daily may be administered to patients who have taken 10mg once daily for at least 3 months.
This medication contains Donepezil Hydrochloride as its main ingredient and is used for the treatment of Alzheimer-type dementia. Firstly, this medication should not be used by individuals who are allergic to Donepezil Hydrochloride or any of its components, pregnant women or women who may become pregnant, and those with lactose intolerance or genetic lactose metabolism disorders. Patients with heart diseases or heart conduction disorders should use this medication cautiously, as bradycardia or arrhythmias may occur during use. Those taking non-steroidal anti-inflammatory drugs (NSAIDs) or with a history of peptic ulcers should be careful, as this medication can promote gastric acid secretion and worsen symptoms. Patients with asthma or obstructive pulmonary diseases should be cautious, as bronchoconstriction and increased mucus secretion may exacerbate their symptoms. Patients with extrapyramidal disorders such as Parkinson's disease may have worsening symptoms due to the cholinergic effects of this medication. This medication contains Yellow No. 4 dye, so individuals allergic to this component should exercise caution. During treatment, serious side effects such as syncope, bradycardia, heart block, gastrointestinal bleeding, liver dysfunction, cerebrovascular issues, movement disorders, severe muscle symptoms, difficulty breathing, acute pancreatitis, and renal failure may occur. If any abnormal symptoms arise, consult a physician immediately. Additionally, relatively common side effects such as nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, headache, fatigue, and others may also occur. This medication should be used under the supervision of a physician experienced in the diagnosis and treatment of dementia symptoms, and treatment efficacy should be evaluated regularly. Patients with heart diseases, electrolyte imbalances, or a history of prolonged QT intervals may require heart monitoring during use. Caution should be exercised when driving or operating machinery, as dizziness, fatigue, and muscle cramps may occur. Pregnant or breastfeeding women should avoid using this medication, and if necessary, should consult with a specialist. This medication may interact with other drugs, so it is essential to inform your doctor or pharmacist, especially if you are taking medications related to CYP3A4 and CYP2D6, heart medications, anticholinergic medications, NSAIDs, etc. In cases of overdose, serious symptoms such as nausea, vomiting, bradycardia, and respiratory depression may occur, and immediate medical attention should be sought. Lastly, this medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture exposure. It is advisable to store it at room temperature, between 1 and 30 degrees Celsius.
Red, biconvex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Donepezil Hydrochloride Hydrate 24mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.